Physician profile
Robb N Larsen
NPI 1396738274
$2,453.92
in general payments reported to CMS, 2019-2025
7 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2022: $140 · 2023: $38.96 · 2024: $17.04 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,132 · Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,132.41 |
| Food and Beverage | $306.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $1,132.41 | 2025 | Amistem, Gmk Sphere |
| Steelhead Surgical INC | $826.00 | 2019 | |
| Stryker Corporation | $291.13 | 2022-2025 | Triathlon |
| Shoulder Innovations, INC. | $98.77 | 2025 | Inset System |
| Heron Therapeutics, INC. | $49.61 | 2019 | |
| Bioventus LLC | $41.71 | 2023-2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $14.29 | 2023 | Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robb Larsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.